Gonadotropin-releasing hormone (GnRH)-I and GnRH-II induce cell growth inhibition in human endometrial cancer cells: Involvement of integrin beta3 and focal adhesion kinase

Reproductive Biology and Endocrinology

Volumn 7, Issue , 2009, Pages

  Park, Dong ^a,c   Choi, Kyung Chul ^b   MacCalman, Colin D ^a   Leung, Peter C K ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Chungbuk National University   (South Korea)

^c Catholic Kwandong University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BETA3 INTEGRIN; FOCAL ADHESION KINASE; GONADORELIN; GONADOTROPIN RELEASING HORMONE 1; GONADOTROPIN RELEASING HORMONE 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; 4-(4-FLUOROPHENYL)-2-(4-HYDROXYPHENYL)-5-(4-PYRIDYL)IMIDAZOLE; DRUG DERIVATIVE; ENZYME INHIBITOR; IMIDAZOLE DERIVATIVE; LHRH, HIS(5) TRP(7) TYR(8); LHRH, HIS(5)-TRP(7)-TYR(8)-; PROGONADOLIBERIN I; PROTEIN PRECURSOR; PYRIDINE DERIVATIVE;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENDOMETRIUM CANCER; ENZYME ACTIVATION; FEMALE; GROWTH INHIBITION; HORMONE ACTION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; DOSE RESPONSE; DRUG ANTAGONISM; ENDOMETRIUM TUMOR; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOMETRIAL NEOPLASMS; ENZYME ACTIVATION; ENZYME INHIBITORS; FEMALE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GONADOTROPIN-RELEASING HORMONE; HUMANS; IMIDAZOLES; INTEGRIN BETA3; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN PRECURSORS; PYRIDINES; SIGNAL TRANSDUCTION;

EID: 70049086395     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-7-81     Document Type: Article

References (43)

1. Engel JB Keller G Schally AV Nagy A Chism DD Halmos G Effective treatment of experimental human endometrial cancers with targeted cytotoxic luteinizing hormone-releasing hormone analogues AN-152 and AN-207 Fertil Steril 2005, 83(Suppl 1):1125-1133. 10.1016/ j.fertnstert.2004.10.042 15831285
2. Wierman ME Bruder JM Kepa JK Regulation of gonadotropin-releasing hormone (GnRH) gene expression in hypothalamic neuronal cells Cell Mol Neurobiol 1995, 15(1):79-88. 10.1007/BF02069559 7648611
3. Neill JD GnRH and GnRH receptor genes in the human genome Endocrinology 2002, 143(3):737-743. 10.1210/en.143.3.737 11861490
4. Santen RJ Clinical review 37: Endocrine treatment of prostate cancer J Clin Endocrinol Metab 1992, 75(3):685-689. 10.1210/jc.75.3.685 1517354
5. Savino L Baldini B Susini T Pulli F Antignani L Massi GB GnRH analogs in gynecological oncology: A review J Chemother 1992, 4(5):312-320. 1479422
6. Schally A Nagy A Targeted cytotoxic analogs of luteinizing hormone-releasing hormone: A reply Eur J Endocrinol 2001, 144(5):559. 10.1530/eje.0.1440559 11331224
7. Schally AV Luteinizing hormone-releasing hormone analogs: Their impact on the control of tumorigenesis Peptides 1999, 20(10):1247-1262. 10.1016/ S0196-9781(99)00130-8 10573298
8. Grundker C Schlotawa L Viereck V Eicke N Horst A Kairies B Emons G Antiproliferative effects of the GnRH antagonist cetrorelix and of GnRH-II on human endometrial and ovarian cancer cells are not mediated through the GnRH type I receptor Eur J Endocrinol 2004, 151(1):141-149. 10.1530/eje.0.1510141 15248835
9. Kim KY Choi KC Park SH Auersperg N Leung PC Extracellular signal-regulated protein kinase, but not c-Jun N-terminal kinase, is activated by type II gonadotropin-releasing hormone involved in the inhibition of ovarian cancer cell proliferation The Journal of clinical endocrinology and metabolism 2005, 90(3):1670-1677. 10.1210/jc.2004-1636 15598681
10. Kim KY Choi KC Park SH Chou CS Auersperg N Leung PC Type II gonadotropin-releasing hormone stimulates p38 mitogen-activated protein kinase and apoptosis in ovarian cancer cells The Journal of clinical endocrinology and metabolism 2004, 89(6):3020-3026. 10.1210/ jc.2003-031871 15181093
11. Choi KC Auersperg N Leung PC Expression and antiproliferative effect of a second form of gonadotropin-releasing hormone in normal and neoplastic ovarian surface epithelial cells The Journal of clinical endocrinology and metabolism 2001, 86(10):5075-5078. 10.1210/jc.86.10.5075 11600588
12. Emons G Schroder B Ortmann O Westphalen S Schulz KD Schally AV High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines J Clin Endocrinol Metab 1993, 77(6):1458-1464. 10.1210/jc.77.6.1458 8263128
13. Noci I Borri P Bonfirraro G Chieffi O Arcangeli A Cherubini A Dabizzi S Buccoliero AM Paglierani M Taddei GL Longstanding survival without cancer progression in a patient affected by endometrial carcinoma treated primarily with leuprolide Br J Cancer 2001, 85(3):333-336. 10.1054/bjoc.2001.1900 11487260
14. Grundker C Gunthert AR Westphalen S Emons G Biology of the gonadotropin-releasing hormone system in gynecological cancers Eur J Endocrinol 2002, 146(1):1-14. 10.1530/eje.0.1460001 11751060
15. Grundker C Volker P Emons G Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase Endocrinology 2001, 142(6):2369-2380. 10.1210/en.142.6.2369 11356684
16. Hood JD Cheresh DA Role of integrins in cell invasion and migration Nat Rev Cancer 2002, 2(2):91-100. 10.1038/nrc727 12635172
17. Pereira JJ Meyer T Docherty SE Reid HH Marshall J Thompson EW Rossjohn J Price JT Bimolecular interaction of insulin-like growth factor (IGF) binding protein-2 with alphavbeta3 negatively modulates IGF-I-mediated migration and tumor growth Cancer Res 2004, 64(3):977-984. 10.1158/ 0008-5472.CAN-03-3056 14871828
18. Moretti RM Montagnani Marelli M Mai S Limonta P Gonadotropin-releasing hormone agonists suppress melanoma cell motility and invasiveness through the inhibition of alpha3 integrin and MMP-2 expression and activity Int J Oncol 2008, 33(2):405-413. 18636163
19. Stupack DG Cheresh DA Get a ligand, get a life: Integrins, signaling and cell survival J Cell Sci 2002, 115(Pt 19):3729-3738. 10.1242/jcs.00071 12235283
20. Lee GS Choi KC Kim HJ Jeung EB Effect of genistein as a selective estrogen receptor beta agonist on the expression of Calbindin-D9k in the uterus of immature rats Toxicol Sci 2004, 82(2):451-457. 10.1093/toxsci/ kfh296 15456916
21. Clayton RN Catt KJ Gonadotropin-releasing hormone receptors: characterization, physiological regulation, and relationship to reproductive function Endocr Rev 1981, 2(2):186-209. 10.1210/ edrv-2-2-186 6271547
22. Huirne JA Lambalk CB Gonadotropin-releasing-hormone-receptor antagonists Lancet 2001, 358(9295):1793-1803. 10.1016/S0140-6736(01)06797-6 11734258
23. Limonta P Moretti RM Marelli MM Motta M The biology of gonadotropin hormone-releasing hormone: Role in the control of tumor growth and progression in humans Front Neuroendocrinol 2003, 24(4):279-295. 10.1016/ j.yfrne.2003.10.003 14726258
24. Davidson L Pawson AJ Millar RP Maudsley S Cytoskeletal reorganization dependence of signaling by the gonadotropin-releasing hormone receptor J Biol Chem 2004, 279(3):1980-1993. 10.1074/jbc.M309827200 14559894
25. Sundaresan S Colin IM Pestell RG Jameson JL Stimulation of mitogen-activated protein kinase by gonadotropin-releasing hormone: evidence for the involvement of protein kinase C Endocrinology 1996, 137(1):304-311. 10.1210/en.137.1.304 8536629
26. Levi NL Hanoch T Benard O Rozenblat M Harris D Reiss N Naor Z Seger R Stimulation of Jun N-terminal kinase (JNK) by gonadotropin-releasing hormone in pituitary alpha T3-1 cell line is mediated by protein kinase C, c-Src, and CDC42 Mol Endocrinol 1998, 12(6):815-824. 10.1210/ me.12.6.815 9626657
27. Roberson MS Zhang T Li HL Mulvaney JM Activation of the p38 mitogen-activated protein kinase pathway by gonadotropin-releasing hormone Endocrinology 1999, 140(3):1310-1318. 10.1210/en.140.3.1310 10067858
28. Cobb MH Goldsmith EJ How MAP kinases are regulated J Biol Chem 1995, 270(25):14843-14846. 10.1074/jbc.270.25.14843 7797459
29. Lessey BA Castelbaum AJ Buck CA Lei Y Yowell CW Sun J Further characterization of endometrial integrins during the menstrual cycle and in pregnancy Fertil Steril 1994, 62(3):497-506. 8062944
30. Lessey BA Damjanovich L Coutifaris C Castelbaum A Albelda SM Buck CA Integrin adhesion molecules in the human endometrium. Correlation with the normal and abnormal menstrual cycle J Clin Invest 1992, 90(1):188-195. 10.1172/JCI115835 443080 1378853
31. Kanamori M Berg Vanden SR Bergers G Berger MS Pieper RO Integrin beta3 overexpression suppresses tumor growth in a human model of gliomagenesis: Implications for the role of beta3 overexpression in glioblastoma multiforme Cancer Res 2004, 64(8):2751-2758. 10.1158/ 0008-5472.CAN-03-3354 15087390
32. Hato T Pampori N Shattil SJ Complementary roles for receptor clustering and conformational change in the adhesive and signaling functions of integrin alphaIIb beta3 J Cell Biol 1998, 141(7):1685-1695. 10.1083/ jcb.141.7.1685 2133003 9647659
33. Borsig L Wong R Feramisco J Nadeau DR Varki NM Varki A Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis Proc Natl Acad Sci USA 2001, 98(6):3352-3357. 10.1073/pnas.061615598 30657 11248082
34. Borsig L Wong R Hynes RO Varki NM Varki A Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis Proc Natl Acad Sci USA 2002, 99(4):2193-2198. 10.1073/pnas.261704098 122341 11854515
35. Taverna D Moher H Crowley D Borsig L Varki A Hynes RO Increased primary tumor growth in mice null for beta3- or beta3/beta5-integrins or selectins Proc Natl Acad Sci USA 2004, 101(3):763-768. 10.1073/ pnas.0307289101 321755 14718670
36. Kraus S Naor Z Seger R Intracellular signaling pathways mediated by the gonadotropin-releasing hormone (GnRH) receptor Arch Med Res 2001, 32(6):499-509. 10.1016/S0188-4409(01)00331-9 11750725
37. Hordijk PL Verlaan I van Corven EJ Moolenaar WH Protein tyrosine phosphorylation induced by lysophosphatidic acid in Rat-1 fibroblasts. Evidence that phosphorylation of map kinase is mediated by the Gi-p21ras pathway J Biol Chem 1994, 269(1):645-651. 8276865
38. Luttrell LM Daaka Y Della Rocca GJ Lefkowitz RJ G protein-coupled receptors mediate two functionally distinct pathways of tyrosine phosphorylation in rat 1a fibroblasts. Shc phosphorylation and receptor endocytosis correlate with activation of Erk kinases J Biol Chem 1997, 272(50):31648-31656. 10.1074/jbc.272.50.31648 9395506
39. Rodriguez-Fernandez JL Why do so many stimuli induce tyrosine phosphorylation of FAK? Bioessays 1999, 21(12):1069-1075. 10.1002/ (SICI)1521-1878(199912)22:1<1069::AID-BIES13>3.0.CO;2-C 10580994
40. Brunton VG MacPherson IR Frame MC Cell adhesion receptors, tyrosine kinases and actin modulators: A complex three-way circuitry Biochim Biophys Acta 2004, 1692(2-3):121-144. 15246683
41. Subauste MC Pertz O Adamson ED Turner CE Junger S Hahn KM Vinculin modulation of paxillin-FAK interactions regulates ERK to control survival and motility J Cell Biol 2004, 165(3):371-381. 10.1083/ jcb.200308011 2172187 15138291
42. Johnson GL Lapadat R Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases Science 2002, 298(5600):1911-1912. 10.1126/science.1072682 12471242
43. Borri P Coronnello M Noci I Pesciullesi A Peri A Caligiani R Maggi M Torricelli F Scarselli G Chieffi O Mazzei T Mini E Differential inhibitory effects on human endometrial carcinoma cell growth of luteinizing hormone-releasing hormone analogues Gynecol Oncol 1998, 71(3):396-403. 10.1006/gyno.1998.5162 9887238